Skip to main content
  • 88 Accesses

Abstract

Cystic fibrosis, an apparent inborn error of metabolism, is a common disease of children and young adults in countries with predominantly Caucasian populations. It was first described by Fanconi et al. in Switzerland following the recognition of the association of congenital cystic pancreatic fibrosis and bronchiectasis in 1936.(1) In this country, it was Andersen(2) who presented in 1938 the first complete description of the disease and introduced the term “cystic fibrosis of the pancreas.” Although other names for the disease have been proposed in the past decades,(3,4) the shortened form of the original name for the disease, “cystic fibrosis,” has become most common. Several detailed reviews have recently appeared in the literature.(3–6)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fanconi, G., E. Uehlinger, and C. Kanuer. 1936. Das Coeliaksyndrom bei angeborener zystischer Pancreasfibromatose and Bronchiectasien. Wien. Med. Wochenschr. 86: 753–760.

    Google Scholar 

  2. Andersen, D. H. 1938. Cystic fibrosis of the pancreas and its relation to celiac disease. Am. J. Dis. Child. 56: 344–351.

    Google Scholar 

  3. Talamo, R. C., B. J. Rosenstein, and R. W. Berninger. 1983. Cystic fibrosis. In: Metabolic Basis of Inherited Disease. J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson, J. L. Goldstein, and M. C. Brown, eds. McGraw-Hill, New York. pp. 1189–1197.

    Google Scholar 

  4. Lobeck, C. C. 1972. Cystic fibrosis. In: Metabolic Basis of Inherited Disease. J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds. McGraw-Hill, New York. pp. 1605–1626.

    Google Scholar 

  5. Quinton, P. M., J. R. Martinez, and U. Hopfer, eds. 1982. Fluid and Electrolyte Abnormalities in Exocrine Glands in Cystic Fibrosis. San Francisco Press, San Francisco.

    Google Scholar 

  6. Davis, P. B., and P. A. di Sant’Agnese. 1980. A review: Cystic fibrosis at forty-Quo Vadis? Pediatr. Res. 14: 83–87.

    CAS  Google Scholar 

  7. di Sant’Agnese, P. A., R. C. Darling, G. A. Perera, and E. Shea. 1953. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas. Pediatrics 12: 549–557.

    Google Scholar 

  8. Gibson, L. E., and R. E. Cooke. 1959. A test for concentration of electrolytes in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23: 545–552.

    PubMed  CAS  Google Scholar 

  9. Schwartz, I. L., and J. H. Thaysen. 1956. Excretion of sodium and potassium in human sweat. J. Clin. Invest. 35: 114–123.

    Article  PubMed  CAS  Google Scholar 

  10. Lobeck, C. C., and D. Huebner. 1962. Effect of age, sex, and cystic fibrosis on the sodium and potassium content of human sweat. Pediatrics 30: 172–178.

    PubMed  CAS  Google Scholar 

  11. Schulz, I., K. J. Ullrich, E. Fromter, H. Holzgrere, A. Frick, and J. Hegel. 1965. Micropunktion and elektrische Potentialmessung an Schweissdrusen des Menschen. Pfluegers Arch. 284: 360–372.

    Article  Google Scholar 

  12. Mangos, J. A., and N. R. McSherry. 1967. Sodium transport: Inhibitory factor in sweat of patients with cystic fibrosis. Science 158: 135–136.

    Article  PubMed  CAS  Google Scholar 

  13. Emrich, J. M., E. Stoll, B. Friolet, J. P. Colombo, R. Richterich, and E. Rossi. 1968. Sweat composition in relation to rate of sweating in patients with cystic fibrosis of the pancreas. Pediatr. Res. 2: 464–476.

    Article  PubMed  CAS  Google Scholar 

  14. Schultz, I. J. 1969. Micropuncture studies of the sweat formation in cystic fibrosis patients. J. Clin. Invest. 48: 1470–1477.

    Article  Google Scholar 

  15. Mangos, J. A. 1973. Microperfusion study of the sweat gland abnormality in cystic fibrosis. Tex. Rep. Biol. Med. 31: 651–663.

    PubMed  CAS  Google Scholar 

  16. Mangos, J. A. 1973. Microperfusion study of the sweat gland abnormality in cystic fibrosis. Tex. Rep. Biol. Med. 31: 651–663.

    PubMed  CAS  Google Scholar 

  17. Quinton, P. M. 1983. Chloride impermeability in cystic fibrosis. Nature (London) 301: 421–422.

    Article  CAS  Google Scholar 

  18. Spicer, S. S., J. V. Briggman, and D. A. Baron. 1982. Morphological and cytochemical correlates of transport in sweat glands of normal and cystic fibrosis subjects. In: Fluid and Electrolyte Abnormalities in Exocrine Glands in Cystic Fibrosis. P. M. Quinton, J. R. Martinez, and U. Hopfer, eds. San Francisco Press, San Francisco. pp. 11–34.

    Google Scholar 

  19. Bartman, J., and B. H. Landing. 1966. Morphology of the sweat apparatus in cystic fibrosis. Am. J. Clin. Pathol. 45: 455–461.

    PubMed  CAS  Google Scholar 

  20. Huebner, D., C. C. Lobeck, and N. R. McSherry. 1966. Density and secretory activity of sweat glands in patients with cystic fibrosis and in healthy controls. Pediatrics 38: 613–620.

    PubMed  CAS  Google Scholar 

  21. Kaiser, D., E. Drack, and E. Rossi. 1970. Effect of cystic fibrosis sweat on sodium reabsorption by the normal sweat gland. Lancet 1: 1003–1004.

    Article  PubMed  CAS  Google Scholar 

  22. Hadorn, B., and A. A. Roscher. 1982. Exocrine pancreatic function in cystic fibrosis. In: Fluid and Electrolyte Abnormalities in Exocrine Glands in Cystic Fibrosis. P. M. Quinton, J. R. Martinez, and U. Hopfer, eds. San Francisco Press, San Francisco. pp. 182–192.

    Google Scholar 

  23. Crossley, J. R., R. B. Elliott, and P. A. Smith. 1979. Dried blood spot screening for cystic fibrosis in the newborn. Lancet 1: 472–474.

    Article  PubMed  CAS  Google Scholar 

  24. Wilcken, B., R. D. Brown, R. Urwin, and D. A. Brown. 1983. Cystic fibrosis screening by dried blood spot trypsin assay: Results in 75,000 newborn infants. J. Pediatr. 102: 383–387.

    Article  PubMed  CAS  Google Scholar 

  25. Figarella, C., J. F. Sauniere, L. Multigner, C. Galabert, M. Amourie, M. Filliat, H. Sarles, and L. P. Chazalette. 1981. Exocrine pancreatic function in cystic fibrosis patients without clinical pancreatic insufficiency with special reference to lactoferrin. Proceedings of the 12th Annual Meeting of the European Working Group for Cystic Fibrosis, Berne.

    Google Scholar 

  26. Martinez, J. R. 1982. Alterations in salivary gland structure and function in cystic fibrosis. In: Fluid and Electrolyte Abnormalities in Exocrine Glands in Cystic Fibrosis. P. M. Quinton, J. R. Martinez, and U. Hopfer, eds. San Francisco Press, San Francisco. pp. 125–142.

    Google Scholar 

  27. Gugler, E., J. C. Pallavicini, H. Swerdlow, and P. A. di Sant’Agnese. 1967. Role of calcium in submaxillary saliva of patients with cystic fibrosis. J. Pediatr. 71: 585–592.

    Article  PubMed  CAS  Google Scholar 

  28. Chernick, W. S., and G. J. Barbero. 1967. Reversal of submaxillary salivary alterations in cystic fibrosis by guanethidine. Fourth International Conference on Cystic Fibrosis of the Pancreas. Mod. Probl. Paediatr. 10: 125–132.

    Google Scholar 

  29. Wiesmann, U. N., T. F. Boat, and P. A. di Sant’Agnese. 1972. Flow rates and electrolytes in minor salivary gland saliva in normal subjects and patients with cystic fibrosis. Lancet 2: 510–512.

    Article  PubMed  CAS  Google Scholar 

  30. Mangos, J. A., N. R. McSherry, and P. J. Benke. 1967. A sodium transport inhibitory factor in the saliva of patients with cystic fibrosis of the pancreas. Pediatr. Res. 1: 436–442.

    Article  PubMed  CAS  Google Scholar 

  31. Mangos, J. A., and N. R. McSherry. 1968. Studies on the mechanism of inhibition of sodium transport in cystic fibrosis of the pancreas. Pediatr. Res. 2: 378–384.

    Article  PubMed  CAS  Google Scholar 

  32. Taylor, A., J. W. Mayo, T. F. Boat, and L. W. Matthews. 1974. Standardized assay for the sodium reabsorption inhibitory effect and studies of its salivary gland distribution in patients with cystic fibrosis. Pediatr. Res. 8: 861–865.

    Article  PubMed  CAS  Google Scholar 

  33. Nadel, J. A., B. Davis, and R. J. Phillips. 1979. Control of mucus secretion and ion transport in airways. Am. Rev. Physiol. 41: 369–391.

    Article  CAS  Google Scholar 

  34. Sturgess, J. 1982. Morphological characteristics of the bronchial mucosa in cystic fibrosis. In: Fluid and Electrolyte Abnormalities in Exocrine Glands in Cystic Fibrosis. P. M. Quinton, J. R. Martinez, and U. Hopfer, eds. San Francisco Press, San Francisco. pp. 254–270.

    Google Scholar 

  35. Oppenheimer, E. 1981. Similarity of the tracheobronchial mucous glands and epithelium in infants with and without cystic fibrosis. Hum. Pathol. 12: 36–52.

    Article  PubMed  CAS  Google Scholar 

  36. Wood, R. E., A. Wanner, J. Hirsch, and P. M. Farrell. 1975. Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. Am. Rev. Respir. Dis. 111: 733–738.

    PubMed  CAS  Google Scholar 

  37. Yeates, D. B., J. M. Sturgess, S. R. Kahn, H. Levison, and N. Aspin. 1976. Mucociliary transport in trachea of patients with cystic fibrosis. Arch. Dis. Child. 51: 28–34.

    Article  PubMed  CAS  Google Scholar 

  38. Wood, R. E., and G. J. Legris. 1982. The role of fluid and electrolyte transport abnormalities in the pulmonary pathophysiology of cystic fibrosis. In: Fluid and Electrolyte Abnormalities in Exocrine Glands in Cystic Fibrosis. P. M. Quinton, J. R. Martinez, and U. Hopfer, eds. San Francisco Press, San Francisco. pp. 289–298.

    Google Scholar 

  39. Boucher. R., C. J. Narvarte, C. Cotton, M. T. Stutts, M. R. Knowles, A. L. Finn, and J. T. Gatzy. 1982. Sodium absorption in mammalian airways. In: Fluid and Electrolyte Abnormalities in Exocrine Glands in Cystic Fibrosis. P. M. Quinton, J. R. Martinez, and U. Hopfer, eds. San Francisco Press, San Francisco. pp. 271–287.

    Google Scholar 

  40. Knowles, M. R., J. Gatzy, and R. Boucher. 1981. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N. Engl. J. Med. 305: 1483–1492.

    Article  Google Scholar 

  41. Spock, A., H. M. C. Heich, and H. Cress. 1967. Abnormal serum factor in patients with cystic fibrosis of the pancreas. Pediatr. Res. 1: 173–177.

    Article  PubMed  CAS  Google Scholar 

  42. Bowman, R. H., L. H. Lockhart, and M. L. McCombs. 1969. Oyster ciliary inhibition by cystic fibrosis factor. Science 164: 325–326.

    Article  PubMed  CAS  Google Scholar 

  43. Schmoyer, I. R., and F. A. Baglia. 1974. Cystic fibrosis: Effect of media from cultured fibroblasts on ATPase activity. Biochem. Biophys. Res. Commun. 58: 1066–1070.

    CAS  Google Scholar 

  44. Farrell, P. M., G. N. Fox, and S. S. Spicer. 1976. Determination and characterization of ciliary ATPase in the presence of serum from cystic fibrosis patients. Pediatr. Res. 10: 127–133.

    Article  PubMed  CAS  Google Scholar 

  45. Doggett, R. G., and G. M. Harrison. 1973. Cystic fibrosis: In vitro reversal of the ciliostatic character of serum and salivary secretions by heparin. Nature New Biol. 243: 251–253.

    Article  PubMed  CAS  Google Scholar 

  46. Carson, S. D., and B. H. Bowman. 1982. Cystic fibrosis. I. Fractionation of the mucociliary inhibitor from plasma. Pediatr. Res. 16: 13–20.

    Article  PubMed  CAS  Google Scholar 

  47. McNeely, M. C., Y. C. Awasthi, D. R. Barrett, T. Iwasumi, L. Schneider, S. Srivastara, and B. H. Bowman. 1982. Cystic fibrosis. II. The urinary mucociliary inhibitor. Pediatr. Res. 16: 21–29.

    Article  PubMed  CAS  Google Scholar 

  48. Blitzer, M. G., and E. Shapiro. 1982. A purified serum glycopeptide from controls and cystic fibrosis patients. I. Comparison of their mucociliary activity on rabbit tracheal explants. Pediatr. Res. 16: 203–208.

    Article  PubMed  CAS  Google Scholar 

  49. Brown, G. A., A. Oshin, M. C. Goodchild, and C. M. Anderson. 1971. Inhibition of sugar transport by plasma from cystic fibrosis patients. Lancet 2: 639–640.

    Article  PubMed  CAS  Google Scholar 

  50. Morin, C. L., J. F. Desjeuz, and L. Authier. 1973. Effect of saliva and serum from patients with cystic fibrosis on intestinal uptake of amnio acids in rat. Biomedicine 19: 133–138.

    Google Scholar 

  51. Taussig, L. M., and J. D. Gardner. 1972. Effects of saliva and plasma from cystic fibrosis patients on membrane transport. Lancet 1: 1367–1369.

    Article  PubMed  CAS  Google Scholar 

  52. Benke, P. J., M. Erbstoeszer, and H. C. Pitot. 1972. Transport of labelled compounds in control and cystic fibrosis cells in vitro. Lancet 1: 182–184.

    Article  PubMed  CAS  Google Scholar 

  53. Araki, H., M. Field, and H. Shwachman. 1975. A new assay for cystic fibrosis factor: Effects of sera from patients with cystic fibrosis on the in vitro electrical properties of rat jejunum. Pediatr. Res. 9: 932–936.

    PubMed  CAS  Google Scholar 

  54. Shapiro, B. L., S. M. Lee, and W. J. Warwick. 1970. The pentose phosphate pathway in cystic fibrosis erythrocytes. Biochem. Biophys. Res. Commun. 39: 816–819.

    Article  PubMed  CAS  Google Scholar 

  55. Bargman, G. J., J. E. Changus, M. Sukup, A. Vale, and H. Pitot. 1975. Effects of cystic fibrosis saliva on inorganic phosphorous esterification by rat liver mitochondria. Pediatr. Res. 9: 31.

    Google Scholar 

  56. Mangos, J. A., N. R. McSherry, P. J. Benke, and A. Spock. 1969. Studies on the pathogenesis of cystic fibrosis: The isoproterenoltreated rat as an experimental model. In: Proceedings of the Fifth Cystic Fibrosis Conference. D. Lawson, ed. Cystic Fibrosis Trust, London. pp. 25–34.

    Google Scholar 

  57. Sturgess, J., and L. Reid. 1973. The effect of isoprenaline and pilocarpine on (a) bronchial mucus-secreting tissue and (b) pancreas, salivary gland, heart, thymus, liver and spleen. Br. J. Exp. Pathol. 54: 388–402.

    PubMed  CAS  Google Scholar 

  58. Martinez, J. R., E. Adelstein, D. Quissel, and G. J. Barbero. 1975. The chronically reserpinized rat as a possible model for cystic fibrosis. I. Submaxillary gland morphology and ultrastructure. Pediatr. Res. 9: 463–469.

    Article  PubMed  CAS  Google Scholar 

  59. Martinez, J. R., P. C. Adshead, D. Quissell, and G. J. Barbero. 1975. The chronically reserpinized rat as a possible model for cystic fibrosis. II. Composition and cilioinhibitory effects of submaxillary saliva. Pediatr. Res. 9: 470–476.

    Article  PubMed  CAS  Google Scholar 

  60. Pivetta, O. H., and E. L. Green. 1973. Exocrine pancreatic insufficiency: A new recessive mutation in mice. J. Hered. 64: 301–302.

    PubMed  CAS  Google Scholar 

  61. Mangos, J. A., G. J. Bargman, J. R. Martinez, and O. M. Rennert. 1976. Physiology and pharmacology of secretion and cystic fibrosis. In: Cystic Fibrosis: Projections into the Future. J. A. Mangos and R. C. Talamo, eds. Stratton Intercontinental Medical Book Corp., New York. pp. 311–336.

    Google Scholar 

  62. Mangos, J. A., N. R. McSherry, and F. Butcher. 1975. Dispersed parotid acinar cells. I. Morphological and functional characterization. Am. J. Physiol. 229: 553–559.

    CAS  Google Scholar 

  63. Mangos, J. A., N. R. McSherry, and T. Barber. 1975. Dispersed parotid acinar cells. II. Characterization of adrenergic receptors. Am. J. Physiol. 229: 560–565.

    PubMed  CAS  Google Scholar 

  64. Mangos, J. A., N. R. McSherry, and T. Barber. 1975. Dispersed rat parotid acinar cells. III. Characterization of cholinergic receptors. Am. J. Physiol. 229: 566–569.

    PubMed  CAS  Google Scholar 

  65. Amsterdam, A., and J. D. Jamieson. 1972. Structural and functional characterization of isolated pancreatic exocrine cells. Proc. Natl. Acad. Sci. USA 69: 3028–3032.

    Article  PubMed  CAS  Google Scholar 

  66. Quissell, D. O., and R. S. Redman. 1979. Functional characteristics of dispersed rat submandibular cells. Proc. Natl. Acad. Sci. USA 76: 2789–2793.

    Article  PubMed  CAS  Google Scholar 

  67. Mangos, J. A. 1979. Morphological and functional characterization of isolated human parotid acinar cells in vitro. J. Dent. Res. 58: 2028–2035.

    Article  PubMed  CAS  Google Scholar 

  68. Mangos, J. A. 1980. Characterization of cholinergic and adrenergic receptors in isolated human parotid acinar cells. J. Dent. Res. 59: 156–163.

    Google Scholar 

  69. Mangos, J. A., and W. H. Donnelly. 1981. Isolated parotid acinar cells from patients with cystic fibrosis: Morphology and composition. J. Dent. Res. 60: 19–25.

    Article  PubMed  CAS  Google Scholar 

  70. Mangos, J. A. 1981. Isolated parotid acinar cells from patients with cystic fibrosis: Functional characterization. J. Dent. Res. 60: 797–804.

    Article  PubMed  CAS  Google Scholar 

  71. Rubin, R. P. 1982. Calcium and Cellular Secretion. Plenum Press, New York.

    Google Scholar 

  72. O’Doherty, J., J. F. Garcia-Diaz, and W. M. Armstrong. 1979. Sodium selective liquid ion-exchanger microelectrodes for intracellular measurements. Science 203: 1349–1351.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Plenum Publishing Corporation

About this chapter

Cite this chapter

Mangos, J.A. (1987). Cystic Fibrosis. In: Andreoli, T.E., Hoffman, J.F., Fanestil, D.D., Schultz, S.G. (eds) Clinical Disorders of Membrane Transport Processes. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1286-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-1286-4_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-42699-5

  • Online ISBN: 978-1-4684-1286-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics